Abstract
ATP-sensitive K+ channels (KATP channels) regulate insulin secretion by coupling intracellular metabolic changes to excitability of the plasma membrane in pancreatic β-cells. The channels are closed when extracellular glucose levels are elevated due to enhanced feature. By contrast, cardiac-type KATP channels, which open in response to metabolic stress during cardiac ischemia, shorten action potential durations. This may contribute to the cardioprotection by decreasing Ca2+ influx through sarcolemma. By sensing intracellular ATP levels or ATP / ADP ratios, changes in activity of KATP channels convert metabolic information into membrane excitability. In addition to channel regulation by nucleotide concentrations, the channel activity is also dependent on the concentrations of membrane phospholipids, including phosphatidyl inositol-4,5-bisphosphate (PIP2). The levels of PIP2 in the membrane may determine the basal activity of the channels. This suggests that channel activity would be modulated by the pathway of receptor-coupled GTPbinding protein (G-protein) and phosphatidyl inositol phospholipase C (PI-PLC) stimulation, which brings about depletion of the membrane PIP2 pool. Thus, KATP channels not only provide interface of metabolic changes with electrical excitation, but also rapidly transmit extracellular signals through receptor-coupled Gprotein and PI-PLC pathway via PIP2 metabolism.
Keywords: atp-sensitive channel, insulin secretion, inwardly rectifying channel, pancreatic, phospholipid, sulfonylurea receptor
Current Medicinal Chemistry
Title: Receptor-Operated Regulation of ATP-Sensitive K+ Channels Via Membrane Phospholipid Metabolism
Volume: 10 Issue: 3
Author(s): M. Kakei
Affiliation:
Keywords: atp-sensitive channel, insulin secretion, inwardly rectifying channel, pancreatic, phospholipid, sulfonylurea receptor
Abstract: ATP-sensitive K+ channels (KATP channels) regulate insulin secretion by coupling intracellular metabolic changes to excitability of the plasma membrane in pancreatic β-cells. The channels are closed when extracellular glucose levels are elevated due to enhanced feature. By contrast, cardiac-type KATP channels, which open in response to metabolic stress during cardiac ischemia, shorten action potential durations. This may contribute to the cardioprotection by decreasing Ca2+ influx through sarcolemma. By sensing intracellular ATP levels or ATP / ADP ratios, changes in activity of KATP channels convert metabolic information into membrane excitability. In addition to channel regulation by nucleotide concentrations, the channel activity is also dependent on the concentrations of membrane phospholipids, including phosphatidyl inositol-4,5-bisphosphate (PIP2). The levels of PIP2 in the membrane may determine the basal activity of the channels. This suggests that channel activity would be modulated by the pathway of receptor-coupled GTPbinding protein (G-protein) and phosphatidyl inositol phospholipase C (PI-PLC) stimulation, which brings about depletion of the membrane PIP2 pool. Thus, KATP channels not only provide interface of metabolic changes with electrical excitation, but also rapidly transmit extracellular signals through receptor-coupled Gprotein and PI-PLC pathway via PIP2 metabolism.
Export Options
About this article
Cite this article as:
Kakei M., Receptor-Operated Regulation of ATP-Sensitive K+ Channels Via Membrane Phospholipid Metabolism, Current Medicinal Chemistry 2003; 10 (3) . https://dx.doi.org/10.2174/0929867033368475
DOI https://dx.doi.org/10.2174/0929867033368475 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Current Medicinal Chemistry A Concise Review on the Role of Natural and Synthetically Derived Peptides in Colorectal Cancer
Current Topics in Medicinal Chemistry Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Apoptogenic Signal Transduction in Arteriosclerosis-Associated Cells – Opportunities for Future Therapy?
Vascular Disease Prevention (Discontinued) The Metabolic Treatment of Patients with Coronary Artery Disease: Effects on Quality of Life and Effort Angina
Current Pharmaceutical Design Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Current Pharmaceutical Biotechnology Structural, Functional and Therapeutic Aspects of Snake Venom Metalloproteinases
Mini-Reviews in Organic Chemistry Astaxanthin and Nrf2 Signaling Pathway: A Novel Target for New Therapeutic Approaches
Mini-Reviews in Medicinal Chemistry Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Islet Compensation in Metabolic Stress: Lessons from Animal Models
Current Diabetes Reviews Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds
Current Cancer Drug Targets Possible Roles of Reg Family Proteins in Pancreatic Islet Cell Growth
Endocrine, Metabolic & Immune Disorders - Drug Targets Unique Challenges of Type 1 Diabetes in the Preschool Population
Current Diabetes Reviews Development of Sol-Gel Hybrid Materials for Whole Cell Immobilization
Recent Patents on Biotechnology Nutriproteomics and Nutrigenomics: Exploring the Mechanism Behind omega-3 Polyunsaturated Fatty Acids, Homocysteine and Glucose Metabolism
Current Proteomics Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets Anti-Oxidative Polyphenolic Compounds of Cocoa
Current Pharmaceutical Biotechnology PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
Endocrine, Metabolic & Immune Disorders - Drug Targets